APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human iPSCs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human iPSCs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17399992032 January 2026185 pages

Choose your research edition.

Industry ResearchHuman iPSCs Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Human iPSCs Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Human iPSCs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human iPSCs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Human iPSCs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Human iPSCs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Human iPSCs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human iPSCs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human iPSCs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human iPSCs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human iPSCs include Sumitomo Dainippon Pharma, ReproCELL, Pluricell Biotech, Ncardia, Fujifilm Holding Corporation (CDI), Fate Therapeutics, Inc, Cell Inspire Biotechnology and Astellas Pharma Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Human iPSCs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human iPSCs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human iPSCs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Human iPSCs market size, projected growth trends, production technologies, key applications, and end-use industries.

Human iPSCs Segment by Company

Sumitomo Dainippon Pharma

ReproCELL

Pluricell Biotech

Ncardia

Fujifilm Holding Corporation (CDI)

Fate Therapeutics, Inc

Cell Inspire Biotechnology

Astellas Pharma Inc

Human iPSCs Segment by Type

Skin

Blood Cells

Human iPSCs Segment by Application

Regenerative Medicine

Drug Development and Discovery

Academic Research

Toxicity Screening

Others

Human iPSCs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human iPSCs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human iPSCs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human iPSCs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Human iPSCs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human iPSCs industry.

Chapter 3: Detailed analysis of Human iPSCs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human iPSCsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human iPSCs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Skin Table 3. Key Players of Blood Cells Table 4. Global Human iPSCs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Regenerative Medicine Table 6. Key Players of Drug Development and Discovery Table 7. Key Players of Academic Research Table 8. Key Players of Toxicity Screening Table 9. Key Players of Others Table 10. Global Human iPSCs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Human iPSCs Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Human iPSCs Market Share by Region (2021-2026) Table 13. Global Human iPSCs Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Human iPSCs Market Share by Region (2027-2032) Table 15. Human iPSCs Industry Trends Table 16. Human iPSCs Industry Drivers Table 17. Human iPSCs Industry Opportunities and Challenges Table 18. Human iPSCs Industry Restraints Table 19. Global Human iPSCs Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Human iPSCs Revenue Market Share by Company (2021-2026) Table 21. Global Human iPSCs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Human iPSCs Key Company Head Office and Area Served Table 23. Global Human iPSCs Company, Product Type & Application Table 24. Global Human iPSCs Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Human iPSCs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Human iPSCs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Human iPSCs Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Human iPSCs Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Human iPSCs Revenue Market Share by Type (2021-2026) Table 31. Global Human iPSCs Revenue Market Share by Type (2027-2032) Table 32. Global Human iPSCs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Human iPSCs Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Human iPSCs Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Human iPSCs Revenue Market Share by Application (2021-2026) Table 36. Global Human iPSCs Revenue Market Share by Application (2027-2032) Table 37. Sumitomo Dainippon Pharma Company Information Table 38. Sumitomo Dainippon Pharma Business Overview Table 39. Sumitomo Dainippon Pharma Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Sumitomo Dainippon Pharma Human iPSCs Product Portfolio Table 41. Sumitomo Dainippon Pharma Recent Development Table 42. ReproCELL Company Information Table 43. ReproCELL Business Overview Table 44. ReproCELL Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. ReproCELL Human iPSCs Product Portfolio Table 46. ReproCELL Recent Development Table 47. Pluricell Biotech Company Information Table 48. Pluricell Biotech Business Overview Table 49. Pluricell Biotech Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Pluricell Biotech Human iPSCs Product Portfolio Table 51. Pluricell Biotech Recent Development Table 52. Ncardia Company Information Table 53. Ncardia Business Overview Table 54. Ncardia Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Ncardia Human iPSCs Product Portfolio Table 56. Ncardia Recent Development Table 57. Fujifilm Holding Corporation (CDI) Company Information Table 58. Fujifilm Holding Corporation (CDI) Business Overview Table 59. Fujifilm Holding Corporation (CDI) Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Fujifilm Holding Corporation (CDI) Human iPSCs Product Portfolio Table 61. Fujifilm Holding Corporation (CDI) Recent Development Table 62. Fate Therapeutics, Inc Company Information Table 63. Fate Therapeutics, Inc Business Overview Table 64. Fate Therapeutics, Inc Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Fate Therapeutics, Inc Human iPSCs Product Portfolio Table 66. Fate Therapeutics, Inc Recent Development Table 67. Cell Inspire Biotechnology Company Information Table 68. Cell Inspire Biotechnology Business Overview Table 69. Cell Inspire Biotechnology Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Cell Inspire Biotechnology Human iPSCs Product Portfolio Table 71. Cell Inspire Biotechnology Recent Development Table 72. Astellas Pharma Inc Company Information Table 73. Astellas Pharma Inc Business Overview Table 74. Astellas Pharma Inc Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Astellas Pharma Inc Human iPSCs Product Portfolio Table 76. Astellas Pharma Inc Recent Development Table 77. North America Human iPSCs Market Size by Type (2021-2026) & (US$ Million) Table 78. North America Human iPSCs Market Size by Type (2027-2032) & (US$ Million) Table 79. North America Human iPSCs Market Size by Application (2021-2026) & (US$ Million) Table 80. North America Human iPSCs Market Size by Application (2027-2032) & (US$ Million) Table 81. North America Human iPSCs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. North America Human iPSCs Market Size by Country (2021-2026) Table 83. North America Human iPSCs Market Size by Country (2027-2032) Table 84. Europe Human iPSCs Market Size by Type (2021-2026) & (US$ Million) Table 85. Europe Human iPSCs Market Size by Type (2027-2032) & (US$ Million) Table 86. Europe Human iPSCs Market Size by Application (2021-2026) & (US$ Million) Table 87. Europe Human iPSCs Market Size by Application (2027-2032) & (US$ Million) Table 88. Europe Human iPSCs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Europe Human iPSCs Market Size by Country (2021-2026) Table 90. Europe Human iPSCs Market Size by Country (2027-2032) Table 91. China Human iPSCs Market Size by Type (2021-2026) & (US$ Million) Table 92. China Human iPSCs Market Size by Type (2027-2032) & (US$ Million) Table 93. China Human iPSCs Market Size by Application (2021-2026) & (US$ Million) Table 94. China Human iPSCs Market Size by Application (2027-2032) & (US$ Million) Table 95. Asia Human iPSCs Market Size by Type (2021-2026) & (US$ Million) Table 96. Asia Human iPSCs Market Size by Type (2027-2032) & (US$ Million) Table 97. Asia Human iPSCs Market Size by Application (2021-2026) & (US$ Million) Table 98. Asia Human iPSCs Market Size by Application (2027-2032) & (US$ Million) Table 99. Asia Human iPSCs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Asia Human iPSCs Market Size by Country (2021-2026) Table 101. Asia Human iPSCs Market Size by Country (2027-2032) Table 102. South America, Middle East & Africa Human iPSCs Market Size by Type (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa Human iPSCs Market Size by Type (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa Human iPSCs Market Size by Application (2021-2026) & (US$ Million) Table 105. South America, Middle East & Africa Human iPSCs Market Size by Application (2027-2032) & (US$ Million) Table 106. South America, Middle East & Africa Human iPSCs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. South America, Middle East & Africa Human iPSCs Market Size by Country (2021-2026) Table 108. South America, Middle East & Africa Human iPSCs Market Size by Country (2027-2032) Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Human iPSCs Product Image Figure 2. Global Human iPSCs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Human iPSCs Market Share by Type: 2025 VS 2032 Figure 4. Skin Image Figure 5. Blood Cells Image Figure 6. Global Human iPSCs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Human iPSCs Market Share by Application: 2025 VS 2032 Figure 8. Regenerative Medicine Image Figure 9. Drug Development and Discovery Image Figure 10. Academic Research Image Figure 11. Toxicity Screening Image Figure 12. Others Image Figure 13. Global Human iPSCs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 15. Global Human iPSCs Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Human iPSCs Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Human iPSCs Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Human iPSCs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Human iPSCs Revenue Market Share by Type (2021-2032) Figure 22. Global Human iPSCs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Human iPSCs Revenue Market Share by Application (2021-2032) Figure 24. North America Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 25. North America Human iPSCs Market Share by Type (2021-2032) Figure 26. North America Human iPSCs Market Share by Application (2021-2032) Figure 27. North America Human iPSCs Market Share by Country (2021-2032) Figure 28. United States Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 29. Canada Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 31. Europe Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 32. Europe Human iPSCs Market Share by Type (2021-2032) Figure 33. Europe Human iPSCs Market Share by Application (2021-2032) Figure 34. Europe Human iPSCs Market Share by Country (2021-2032) Figure 35. Germany Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 36. France Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 38. Italy Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 39. Russia Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 41. China Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 42. China Human iPSCs Market Share by Type (2021-2032) Figure 43. China Human iPSCs Market Share by Application (2021-2032) Figure 44. Asia Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 45. Asia Human iPSCs Market Share by Type (2021-2032) Figure 46. Asia Human iPSCs Market Share by Application (2021-2032) Figure 47. Asia Human iPSCs Market Share by Country (2021-2032) Figure 48. Japan Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 52. India Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 53. Australia Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Human iPSCs Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Human iPSCs Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Human iPSCs Market Share by Country (2021-2032) Figure 58. Brazil Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 63. UAE Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 65. Chile Human iPSCs Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Skin
  • Blood Cells
Applications
  • Regenerative Medicine
  • Drug Development and Discovery
  • Academic Research
  • Toxicity Screening
  • Others
Companies covered
  • Sumitomo Dainippon Pharma
  • ReproCELL
  • Pluricell Biotech
  • Ncardia
  • Fujifilm Holding Corporation (CDI)
  • Fate Therapeutics, Inc
  • Cell Inspire Biotechnology
  • Astellas Pharma Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Human iPSCs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Skin
  5. 1.2.3 Blood Cells
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Human iPSCs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Regenerative Medicine
  9. 1.3.3 Drug Development and Discovery
  10. 1.3.4 Academic Research
  11. 1.3.5 Toxicity Screening
  12. 1.3.6 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Human iPSCs Growth Trends by Region
  15. 1.5.1 Global Human iPSCs Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Human iPSCs Market Size by Region (2021-2026)
  17. 1.5.3 Human iPSCs Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Human iPSCs Market Dynamics
  1. 2.1 Human iPSCs Industry Trends
  2. 2.2 Human iPSCs Industry Drivers
  3. 2.3 Human iPSCs Industry Opportunities and Challenges
  4. 2.4 Human iPSCs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Human iPSCs Revenue by Company (2021-2026)
  2. 3.2 Global Human iPSCs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Human iPSCs Key Company Head office and Area Served
  4. 3.4 Global Human iPSCs Company, Product Type & Application
  5. 3.5 Global Human iPSCs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Human iPSCs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Human iPSCs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Human iPSCs Tier 1, Tier 2, and Tier 3
4 Human iPSCs Market by Type
  1. 4.1 Global Human iPSCs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Human iPSCs Market Size by Type (2021-2032)
  3. 4.3 Global Human iPSCs Market Size Share by Type (2021-2032)
5 Human iPSCs Market by Application
  1. 5.1 Global Human iPSCs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Human iPSCs Market Size by Application (2021-2032)
  3. 5.3 Global Human iPSCs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sumitomo Dainippon Pharma
  2. 6.1.1 Sumitomo Dainippon Pharma Company Information
  3. 6.1.2 Sumitomo Dainippon Pharma Business Overview
  4. 6.1.3 Sumitomo Dainippon Pharma Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sumitomo Dainippon Pharma Human iPSCs Product Portfolio
  6. 6.1.5 Sumitomo Dainippon Pharma Recent Developments
  7. 6.2 ReproCELL
  8. 6.2.1 ReproCELL Company Information
  9. 6.2.2 ReproCELL Business Overview
  10. 6.2.3 ReproCELL Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 ReproCELL Human iPSCs Product Portfolio
  12. 6.2.5 ReproCELL Recent Developments
  13. 6.3 Pluricell Biotech
  14. 6.3.1 Pluricell Biotech Company Information
  15. 6.3.2 Pluricell Biotech Business Overview
  16. 6.3.3 Pluricell Biotech Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pluricell Biotech Human iPSCs Product Portfolio
  18. 6.3.5 Pluricell Biotech Recent Developments
  19. 6.4 Ncardia
  20. 6.4.1 Ncardia Company Information
  21. 6.4.2 Ncardia Business Overview
  22. 6.4.3 Ncardia Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Ncardia Human iPSCs Product Portfolio
  24. 6.4.5 Ncardia Recent Developments
  25. 6.5 Fujifilm Holding Corporation (CDI)
  26. 6.5.1 Fujifilm Holding Corporation (CDI) Company Information
  27. 6.5.2 Fujifilm Holding Corporation (CDI) Business Overview
  28. 6.5.3 Fujifilm Holding Corporation (CDI) Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Fujifilm Holding Corporation (CDI) Human iPSCs Product Portfolio
  30. 6.5.5 Fujifilm Holding Corporation (CDI) Recent Developments
  31. 6.6 Fate Therapeutics, Inc
  32. 6.6.1 Fate Therapeutics, Inc Company Information
  33. 6.6.2 Fate Therapeutics, Inc Business Overview
  34. 6.6.3 Fate Therapeutics, Inc Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Fate Therapeutics, Inc Human iPSCs Product Portfolio
  36. 6.6.5 Fate Therapeutics, Inc Recent Developments
  37. 6.7 Cell Inspire Biotechnology
  38. 6.7.1 Cell Inspire Biotechnology Company Information
  39. 6.7.2 Cell Inspire Biotechnology Business Overview
  40. 6.7.3 Cell Inspire Biotechnology Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Cell Inspire Biotechnology Human iPSCs Product Portfolio
  42. 6.7.5 Cell Inspire Biotechnology Recent Developments
  43. 6.8 Astellas Pharma Inc
  44. 6.8.1 Astellas Pharma Inc Company Information
  45. 6.8.2 Astellas Pharma Inc Business Overview
  46. 6.8.3 Astellas Pharma Inc Human iPSCs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Astellas Pharma Inc Human iPSCs Product Portfolio
  48. 6.8.5 Astellas Pharma Inc Recent Developments
7 North America
  1. 7.1 North America Human iPSCs Market Size (2021-2032)
  2. 7.2 North America Human iPSCs Market Size by Type
  3. 7.2.1 North America Human iPSCs Market Size by Type (2021-2026)
  4. 7.2.2 North America Human iPSCs Market Size by Type (2027-2032)
  5. 7.2.3 North America Human iPSCs Market Share by Type (2021-2032)
  6. 7.3 North America Human iPSCs Market Size by Application
  7. 7.3.1 North America Human iPSCs Market Size by Application (2021-2026)
  8. 7.3.2 North America Human iPSCs Market Size by Application (2027-2032)
  9. 7.3.3 North America Human iPSCs Market Share by Application (2021-2032)
  10. 7.4 North America Human iPSCs Market Size by Country
  11. 7.4.1 North America Human iPSCs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Human iPSCs Market Size by Country (2021-2026)
  13. 7.4.3 North America Human iPSCs Market Size by Country (2027-2032)
  14. 7.4.4 North America Human iPSCs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Human iPSCs Market Size (2021-2032)
  2. 8.2 Europe Human iPSCs Market Size by Type
  3. 8.2.1 Europe Human iPSCs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Human iPSCs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Human iPSCs Market Share by Type (2021-2032)
  6. 8.3 Europe Human iPSCs Market Size by Application
  7. 8.3.1 Europe Human iPSCs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Human iPSCs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Human iPSCs Market Share by Application (2021-2032)
  10. 8.4 Europe Human iPSCs Market Size by Country
  11. 8.4.1 Europe Human iPSCs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Human iPSCs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Human iPSCs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Human iPSCs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Human iPSCs Market Size (2021-2032)
  2. 9.2 China Human iPSCs Market Size by Type
  3. 9.2.1 China Human iPSCs Market Size by Type (2021-2026)
  4. 9.2.2 China Human iPSCs Market Size by Type (2027-2032)
  5. 9.2.3 China Human iPSCs Market Share by Type (2021-2032)
  6. 9.3 China Human iPSCs Market Size by Application
  7. 9.3.1 China Human iPSCs Market Size by Application (2021-2026)
  8. 9.3.2 China Human iPSCs Market Size by Application (2027-2032)
  9. 9.3.3 China Human iPSCs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Human iPSCs Market Size (2021-2032)
  2. 10.2 Asia Human iPSCs Market Size by Type
  3. 10.2.1 Asia Human iPSCs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Human iPSCs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Human iPSCs Market Share by Type (2021-2032)
  6. 10.3 Asia Human iPSCs Market Size by Application
  7. 10.3.1 Asia Human iPSCs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Human iPSCs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Human iPSCs Market Share by Application (2021-2032)
  10. 10.4 Asia Human iPSCs Market Size by Country
  11. 10.4.1 Asia Human iPSCs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Human iPSCs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Human iPSCs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Human iPSCs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Human iPSCs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Human iPSCs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Human iPSCs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Human iPSCs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Human iPSCs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Human iPSCs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Human iPSCs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Human iPSCs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Human iPSCs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Human iPSCs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Human iPSCs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Human iPSCs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Human iPSCs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Human iPSCs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst